Three AI Stocks To Buy That Aren't Nvidia
Nvidia has returned 700% during the Age of AI, but smaller companies may have more room to run. Pfizer, Tesla, and Kroger are ...
pharmaphorum5d
Pfizer selects once-daily GLP-1 for its obesity push
According to the group’s soon-to-depart chief scientific officer, Mikael Dolsten, Pfizer has a “robust pipeline” of three clinical and several preclinical candidates. While danuglipron has ...
pharmaphorum1d
AbbVie lines up Thakkar to replace outgoing CSO Hudson
It’s the second major change at the top of a big pharma group to be announced this week, after Pfizer’s chief scientific officer and president of R&D, Mikael Dolsten, also announced his ...
Investing4d
Pfizer's SWOT analysis: pharmaceutical giant's stock faces challenges and opportunities
Pfizer Inc. (NYSE:PFE), one of the world's largest pharmaceutical companies, has been navigating a complex landscape of challenges and opportunities in recent years. The company's stock has faced ...
Yahoo Finance5d
Pfizer (PFE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Pfizer (PFE) reports results for the quarter ended September 2024. While this widely-known consensus outlook is ...
Yahoo Finance6d
Pfizer (PFE) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest market close, Pfizer (PFE) reached $28.93, with a -0.99% movement compared to the previous day. The stock's change was less than the S&P 500's daily loss of 0.18%. Elsewhere ...
Business Insider6d
Pfizer announces FDA approval of Abrysvo
Pfizer (PFE) announced that the U.S. FDA has approved Abrysvo, the company’s bivalent RSV prefusion F vaccine, for the prevention of lower respiratory tract disease caused by RSV in individuals ...
Business Insider5d
Pfizer: CDC Advisory Committee expands recommendation for use of Prevnar 20
Pfizer (PFE) announced that the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practice voted to expand its recommendation for the use of certain ...
Stockhouse5d
U.S. FDA Approves Pfizer's RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vaccine), the company’s bivalent ...
Yahoo Finance6d
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease
NEW YORK, October 22, 2024--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine), the ...
CBSSports.com5d
Sharks' Mikael Granlund: Nets first goal of season
Granlund scored a power-play goal on five shots and added two PIM in Tuesday's 3-1 loss to the Ducks. Granlund's goal at 4:55 of the third period briefly tied the game at 1-1. The 32-year-old had ...